Paclitaxel, estramustine, and etoposide in the treatment of hormone- refractory prostate cancer

K. J. Pienta, D. C. Smith

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Paclitaxel, estramustine, and etoposide in the treatment of hormone- refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences